开放获取的出版物数量
查看全部2 篇文章
0 篇文章
可查看的文章
无法查看的文章
根据资助方的强制性开放获取政策
合著作者
M.Reza Hormozi-NezhadProfessor of Chemistry Department, Sharif University of Technology在 sharif.edu 的电子邮件经过验证- Forough GhasemiAssistant Professor, Agricultural Biotechnology Research Institute of Iran在 abrii.ac.ir 的电子邮件经过验证
- Nafiseh Fahimi-KashaniIsfahan University of Technology在 iut.ac.ir 的电子邮件经过验证
- Mohammad Amin Farahmand NejadSharif University of Technology在 ch.sharif.edu 的电子邮件经过验证
- Morteza MahmoudiAssociate Professor, Michigan State University在 msu.edu 的电子邮件经过验证
- Hamed GolmohammadiHumboldt Fellow at University of Freiburg, Assistant Professor/Group Leader at CCERCI在 ccerci.ac.ir 的电子邮件经过验证
- Vincent RotelloDepartment of Chemistry, U. Massachusetts在 chem.umass.edu 的电子邮件经过验证
- Giulio CaraccioloDepartment of Molecular Medicine, Sapienza University of Rome在 uniroma1.it 的电子邮件经过验证
- Ahmad MoslehipourLab Manager (GSP), Bushehr Petrochemical Company (BUPC)在 bupc.ir 的电子邮件经过验证
- Akash GuptaMassachusetts Institute of Technology, Postdoc Anderson/Langer Lab在 mit.edu 的电子邮件经过验证
- Riddha DasHarvard Medical School, Postdoc Weissleder lab在 mgh.harvard.edu 的电子邮件经过验证
- Khatereh MotamedchabokiChair, HUPO Industry Advisory Board, Sr. Global Product Marketing Manager, Translational Research在 thermofisher.com 的电子邮件经过验证
- Ryan F. LandisManager at Landis Ventures, LLC在 chem.umass.edu 的电子邮件经过验证
- Hadi ParastarAssociate Professor of Analytical Chemistry, Sharif University of在 sharif.edu 的电子邮件经过验证
- Pezhman SasanpourProfessor at School of Medicine, Shahid Beheshti Medical University在 sbmu.ac.ir 的电子邮件经过验证
- Mahmoud Ghazi-KhansariSchool of Medicine, Tehran University of Medical Sciences在 sina.tums.ac.ir 的电子邮件经过验证
- Rubul Mout, Ph.D.Harvard Medical School, Harvard University | Stem Cell Program at Boston Children's Hospital在 childrens.harvard.edu 的电子邮件经过验证
- Yi-Wei LeeUniversity of Massachusetts Amherst在 umass.edu 的电子邮件经过验证
- Xiaoning LiCollege of Pharmacy at OSU/OHSU在 ohsu.edu 的电子邮件经过验证
- Neveen SalehAssistant professor of Microbiology, Egyptian Drug Authority (format National Organization for Drug
